Changes in T cell subsets identify responders to FcR non-binding anti-CD3 mAb (teplizumab) in patients with Type 1 diabetes

相似書籍

• Analysis of FcR non-binding anti-CD3 mAb in humanized mice identifies novel human gut tropic cells with regulatory function that are found in patients
  由: Waldron-Lynch, Frank, et al.
  出版: (2012)
• Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3γ1(Ala-Ala)
  由: Herold, Kevan C., et al.
  出版: (2003)
• Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
  由: Herold, Kevan C., et al.
  出版: (2013)
• Immunological properties of Fc receptor on lymphocytes. VIII. The behaviour of FcR+ and FcR- T cells in cell-mediated immune responses.
  由: Takabayashi, A, et al.
  出版: (1980)
• Human FcR Polymorphism and Disease
  由: Li, Xinrui, et al.
  出版: (2014)